Fourth, editing of the tumor suppressor miR-200b weakened its interaction with the target gene ZEB1 in thyroid cancer, and the editing inhibitor 8-azaadenosine diminished aggressiveness of thyroid cancer cells [87]. This evidence concerns the gene ZEB1 and thyroid cancer.